{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:21:50Z","timestamp":1793089310432,"version":"4.5.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>IL-10-producing regulatory B (Breg) cells are well recognized for maintaining immune tolerance. The impaired Breg cell function with decreased IL-10-producing capacity has been found in autoimmune diseases, such as rheumatoid arthritis, lupus, and primary Sjogren's syndrome (pSS). However, seldom therapeutic agents targeting Breg cells are available to treat those autoimmune diseases. Here, we showed that acteoside (AC), a caffeoyl phenylethanoid glycoside from a medicinal herb Radix Rehmanniae, could promote IL-10 production from both human and murine B cells via critically regulating the TLR4\/PI3K axis. Moreover, TLR4 was found increased in Breg cells from mice with experimental SS (ESS), a mouse model that recapitulates human pSS. Thus, B cells from the ESS mice were susceptible to AC treatment, showing higher IL-10-producing capacity than those from na\u00efve controls. In addition, AC treatment also promoted the production of IL-10 from TLR4+CXCR4+ plasma cells of ESS mice. Notably, we found that AC was able to enter lymphoid organs upon oral administration. AC treatment effectively increased IL-10+ B cells in ESS mice and ameliorated disease pathology accompanied by reduced T effector cells, including Th17 and T follicular helper cells in the ESS mice. In conclusion, AC could promote Breg cell function and attenuate ESS pathology in vivo, which may be a promising drug candidate for treating pSS and other autoimmune diseases.<\/jats:p>","DOI":"10.1002\/jlb.3ma0422-510r","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:22:42Z","timestamp":1653996162000},"page":"875-885","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity"],"prefix":"10.1093","volume":"112","author":[{"given":"Meiling","family":"Wu","sequence":"first","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulan","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacun","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Meng","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"},{"name":"Workstation for Training and Research (Hong Kong Branch), Distinguished Professor Yu Jin Gynaecology of Chinese Medicine & Integrative Medicine , Hong Kong SAR, China"},{"name":"Workstation of Zhu Nansun, National Master of Chinese Medicine, Hong Kong Branch of Zhu's School of Gynaecology of Chinese Medicine from Shanghai , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyong","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People's Hospital , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Shen","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12176","article-title":"B10 cell regulation of health and disease","volume":"259","author":"Candando","year":"2014","journal-title":"Immunol Rev"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.38666","article-title":"Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity","volume":"66","author":"Daien","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41423-019-0227-z","article-title":"IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjogren's syndrome","volume":"16","author":"Lin","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","article-title":"Cytometry by time-of-flight immunophenotyping identifies a blood Sjogren's signature correlating with disease activity and glandular inflammation","volume":"137","author":"Mingueneau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sjogren's syndrome","volume":"74","author":"Lin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20170901","article-title":"Deficiency in T follicular regulatory cells promotes autoimmunity","volume":"215","author":"Fu","year":"2018","journal-title":"J Exp Med"},{"key":"2023032107564413800_","article-title":"T cells in primary Sjogren's syndrome: targets for early intervention","volume-title":"Rheumatology (Oxford)","author":"Verstappen","year":"2019"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/intimm\/dxr066","article-title":"An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjogren's syndrome","volume":"23","author":"Lin","year":"2011","journal-title":"Int Immunol"},{"key":"2023032107564413800_","first-page":"45","article-title":"Application law of prescriptions and TCM medicine on treating sjogren syndrome in TCM","volume":"10","author":"Zhen","year":"2018","journal-title":"China Acad J Electron Publish House"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3389\/fphys.2018.00864","article-title":"Radix Rehmanniae extract ameliorates experimental autoimmune encephalomyelitis by suppressing macrophage-derived nitrative damage","volume":"9","author":"Li","year":"2018","journal-title":"Front Physiol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2019.10.408","article-title":"Acteoside ameliorates experimental autoimmune encephalomyelitis through inhibiting peroxynitrite-mediated mitophagy activation","volume":"146","author":"Li","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","volume":"182","author":"Yanaba","year":"2009","journal-title":"J Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cmi.2012.60","article-title":"Regulatory B cells in autoimmune diseases","volume":"10","author":"Yang","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1189\/jlb.1208763","article-title":"TLR4\/MyD88\/PI3K interactions regulate TLR4 signaling","volume":"85","author":"Laird","year":"2009","journal-title":"J Leukoc Biol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2567.2010.03402.x","article-title":"Interleukin-10-induced gene expression and suppressive function are selectively modulated by the PI3K-Akt-GSK3 pathway","volume":"132","author":"Antoniv","year":"2011","journal-title":"Immunology"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-014-0057-5","article-title":"Toll-like receptors in the pathogenesis of human B cell malignancies","volume":"7","author":"Isaza-Correa","year":"2014","journal-title":"J Hematol Oncol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","article-title":"TLR2 and TLR4 in autoimmune diseases: a comprehensive review","volume":"47","author":"Liu","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/annrheumdis-2018-213615","article-title":"TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus","volume":"77","author":"Ma","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","article-title":"Stem cells: units of development, units of regeneration, and units in evolution","volume":"100","author":"Weissman","year":"2000","journal-title":"Cell"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice","volume":"43","author":"Nguyen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041287","article-title":"Aquaporin 1, 3, and 5 patterns in salivary gland mucoepidermoid carcinoma: expression in surgical specimens and an in vitro pilot study","volume":"21","author":"Stamboni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10875-016-0263-8","article-title":"New insights into IL-10 dependent and IL-10 independent mechanisms of regulatory B cell immune suppression","volume":"36","author":"Floudas","year":"2016","journal-title":"J Clin Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-021-00498-5","article-title":"B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies","volume":"17","author":"Cencioni","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and effector B cells: friends or foes?","volume":"93","author":"Matsushita","year":"2019","journal-title":"J Dermatol Sci"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","volume":"180","author":"Lampropoulou","year":"2008","journal-title":"J Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.1600218","article-title":"Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients","volume":"198","author":"Banko","year":"2017","journal-title":"J Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1038\/s41467-020-17179-4","article-title":"Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate","volume":"11","author":"Bibby","year":"2020","journal-title":"Nat Commun"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","article-title":"Toll-like receptor pathways in autoimmune diseases","volume":"50","author":"Chen","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1002\/art.24140","article-title":"Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis","volume":"58","author":"Ospelt","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.autrev.2016.12.003","article-title":"TLRs, future potential therapeutic targets for RA","volume":"16","author":"Elshabrawy","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2023032107564413800_","first-page":"75","article-title":"Role of toll-like receptors in multiple sclerosis","volume":"2","author":"Miranda-Hernandez","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.3389\/fimmu.2019.02963","article-title":"Activation of Myd88-dependent TLRs mediates local and systemic inflammation in a mouse model of primary Sjogren's syndrome","volume":"10","author":"Kiripolsky","year":"2019","journal-title":"Front Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.4049\/jimmunol.173.11.7070","article-title":"TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease","volume":"173","author":"Kerfoot","year":"2004","journal-title":"J Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/eji.200737187","article-title":"Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis","volume":"38","author":"Marta","year":"2008","journal-title":"Eur J Immunol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE","volume":"203","author":"Ehlers","year":"2006","journal-title":"J Exp Med"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory role of TLR-MyD88 signaling in multiple sclerosis","volume":"12","author":"Zheng","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102608","article-title":"Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjogren's syndrome","volume":"118","author":"Kiripolsky","year":"2021","journal-title":"J Autoimmun"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1038\/srep09541","article-title":"The core pattern analysis on chinese herbal medicine for Sjogren's syndrome: a nationwide population-based study","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jep.2014.05.049","article-title":"The traditional Chinese medicine prescription patterns of Sjogrens patients in Taiwan: a population-based study","volume":"155","author":"Yu","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"2023032107564413800_","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109806","article-title":"Catalpol ameliorates Sjogren's Syndrome by modulating interplay of T and B cells","volume":"123","author":"Lin","year":"2020","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.3MA0422-510R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.3MA0422-510R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/4\/875\/49471782\/jlb11153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/4\/875\/49471782\/jlb11153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T12:33:29Z","timestamp":1700656409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/112\/4\/875\/6976240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,5,31]]},"published-print":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.3ma0422-510r","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"2021-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}